Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S PESONEN

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Interventions in Aging|February 19, 2024
Do LUTS Predict Mortality? An Analysis Using Random Forest AlgorithmsJonne Åkerla, Jaakko Nevalainen, Jori S Pesonen, et al.
The Journal of Urology|April 26, 2022
Lower Urinary Tract Symptoms and Mortality among Finnish Men: The Roles of Symptom Severity and BotherJonne Åkerla, Jori S Pesonen, Antti Pöyhönen, et al.
Prostate Cancer and Prostatic Diseases|November 10, 2018
Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish menJonne Åkerla, Jori S Pesonen, Antti Pöyhönen, et al.
Scandinavian Journal of Urology|February 26, 2024
Do men adapt to lower urinary tract symptoms? An 11-year longitudinal study of male urinary urgency and associated botherJonne Åkerla, Jori S Pesonen, Essi Peltonen, et al.
Gene Therapy|November 11, 2011
Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4J D Dias, O Hemminki, I Diaconu, et al.
Cancer Gene Therapy|December 25, 2010
Oncolytic adenovirus based on serotype 3O Hemminki, G Bauerschmitz, S Hemmi, et al.
Cancer Gene Therapy|November 19, 2011
Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases developmentS Lavilla-Alonso, M M T Bauer, U Abo-Ramadan, et al.
Gene Therapy|August 30, 2008
Extended release of adenovirus from silica implants in vitro and in vivoL Kangasniemi, M Koskinen, M Jokinen, et al.
International Journal of Cancer|November 20, 2013
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus respondersO Hemminki, R Immonen, J Närväinen, et al.
Gene Therapy|March 19, 2010
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumorsS Pesonen, P Nokisalmi, S Escutenaire, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Interventions in Aging|February 19, 2024
Do LUTS Predict Mortality? An Analysis Using Random Forest AlgorithmsJonne Åkerla, Jaakko Nevalainen, Jori S Pesonen, et al.
The Journal of Urology|April 26, 2022
Lower Urinary Tract Symptoms and Mortality among Finnish Men: The Roles of Symptom Severity and BotherJonne Åkerla, Jori S Pesonen, Antti Pöyhönen, et al.
Prostate Cancer and Prostatic Diseases|November 10, 2018
Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly Finnish menJonne Åkerla, Jori S Pesonen, Antti Pöyhönen, et al.
Scandinavian Journal of Urology|February 26, 2024
Do men adapt to lower urinary tract symptoms? An 11-year longitudinal study of male urinary urgency and associated botherJonne Åkerla, Jori S Pesonen, Essi Peltonen, et al.
Gene Therapy|November 11, 2011
Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4J D Dias, O Hemminki, I Diaconu, et al.
Cancer Gene Therapy|December 25, 2010
Oncolytic adenovirus based on serotype 3O Hemminki, G Bauerschmitz, S Hemmi, et al.
Cancer Gene Therapy|November 19, 2011
Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases developmentS Lavilla-Alonso, M M T Bauer, U Abo-Ramadan, et al.
Gene Therapy|August 30, 2008
Extended release of adenovirus from silica implants in vitro and in vivoL Kangasniemi, M Koskinen, M Jokinen, et al.
International Journal of Cancer|November 20, 2013
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus respondersO Hemminki, R Immonen, J Närväinen, et al.
Gene Therapy|March 19, 2010
Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumorsS Pesonen, P Nokisalmi, S Escutenaire, et al.
Pageof 3